Skip to content

Individualised Homoeopathic medicine in centesimal potencies versus LM potencies in cases of psoriasis

An analytical comparison of individualised homoeopathic medicine in centesimal potencies versus LM potencies for the management of psoriasis - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/058058
Enrollment
96
Registered
2023-09-26
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L401- Generalized pustular psoriasis

Interventions

Intervention1: Individualized Homoeopathic medicine in LM potencies: Intervention is planned as administering indicated homoeopathic medicine in LM potencies. In this potency a single medicated cane s

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pre-diagnosed or cases having clinical features of Psoriasis. Cases of Psoriasis seeking treatment from any other system of medicines like Allopathy, Ayurvedic, etc., will be considered after a washout period of 1 month. Patients seeking Homoeopathic treatment prior to the visit will also be taken into consideration after 1 month of washout period. Adult age group 18 years to 65 years. The patients giving their consent to participate in study with six follow ups.

Exclusion criteria

Exclusion criteria: The psoriasis cases with other comorbidities. The psoriasis cases with psoriatic arthritis. Participants with other co-existing skin conditions. Pregnant and Lactating mother. The case without proper follow-up and discontinuation of treatment in between the study will be dropped out.

Design outcomes

Primary

MeasureTime frame
To compare individualised homoeopathic medicine in centesimal potencies versus LM potencies the management of psoriasis.Timepoint: 3rd Month, 6th month

Secondary

MeasureTime frame
To clinically assess treatment outcome in cases of psoriasis using Psoriasis Area & Severity Index (PASI) Timepoint: 3rd Month, 6 Month;To study the role individualised homoeopathic medicine in psoriasisTimepoint: 6 Months

Countries

India

Contacts

Public ContactDr Amit Nayak

Ahemedabad Homoeoapathic Medical College

heena.rawalahmc@paruluniversity.ac.in9427401176

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026